
Opinion|Videos|August 6, 2024
Looking Ahead: Expert Future Perspectives in the HR+ Breast Cancer Landscape
A panel of experts offer future perspectives in HR+ breast cancer.
Advertisement
Episodes in this series

Video content above is prompted by the following:
What other potential advances are you excited about in the HR+ BC space?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
4
Dr Spencer on First-Line Chemo Selection in Metastatic Pancreatic Adenocarcinoma
5

































